As a fonder of Palo Santo and Bridge Investments, Daniel has ben actively investing with and supporting inspired entrepreneurs for 20 years. Years ago he saw the potential of psychedelic medicines and has developed a deep network of relationships across the psychedelic research and business communities. His passion for the space is purpose-driven and science informed. He is thrilled to be a part of Palo Santo's mission of supporting promising treatments while ensuring widespread access to safe, legal, and effective solutions.